Hadija Trojer

839 citations
14 papers · 346 indexed · h-index 7
Topics
Inflammasome and immune disorders (9 papers)interferon and immune responses (3 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers)

In The Last Decade

Hadija Trojer

11 papers receiving 338 citations

Peers

Hadija Trojer
Comparison fields: 5 of 45
  • Molecular Biology 282
  • Immunology 168
  • Rheumatology 80
  • Hematology 78
  • Nephrology 52
Replace Anna Baginska with:
Anna Baginska United Kingdom
Evelien J. Bodar Netherlands
Laura Dickie United Kingdom
V. Martínez-Taboada Spain
Oskar Schnappauf United States
Linqing Zhong China
Jamil Al-Alami Jordan
Konstantia-Maria Chavele United Kingdom
Rozenn Le Corre France
Marguerite Vignon France
Hadija Trojer relative to Anna Baginska United Kingdom Anna Baginska's profile →
Citations per field
00.5×1.5×
Anna Baginska · 1×
Citations per year

Countries citing papers authored by Hadija Trojer

Since Specialization
Citations

This map shows the geographic impact of Hadija Trojer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hadija Trojer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hadija Trojer more than expected).

Fields of papers citing papers by Hadija Trojer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hadija Trojer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hadija Trojer. The network helps show where Hadija Trojer may publish in the future.

Co-authorship network of co-authors of Hadija Trojer

This figure shows the co-authorship network connecting the top 25 collaborators of Hadija Trojer. A scholar is included among the top collaborators of Hadija Trojer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hadija Trojer. Hadija Trojer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 14
2 0
3 29
4 95
5 68
6 43
7 0
8 43
9 5
10 4
11 1
12 43
13 0
14
Natural history of hereditary lysozyme amyloidosis
1

About Hadija Trojer

Hadija Trojer is a scholar working on Nephrology, Immunology and Rheumatology, having authored 14 papers that have together received 346 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (9 papers), interferon and immune responses (3 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). The work is most often cited by research in Immunology (168 citations), Nephrology (52 citations) and Hematology (78 citations). Hadija Trojer has collaborated with scholars based in United Kingdom, Spain and Poland. Frequent co-authors include Helen J. Lachmann, Philip N. Hawkins, Dorota Rowczenio, Thirusha Lane, Anna Baginska, Paul Brogan, Ebun Omoyinmi, Anna Mensa‐Vilaró, Juan I. Aróstegui and Julian D. Gillmore. Their work appears in journals such as Blood, Frontiers in Immunology and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026